Fentrazamide Metabolite
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category | Others |
Catalog number | BBF-04545 |
CAS | 98377-35-6 |
Molecular Weight | 196.59 |
Molecular Formula | C7H5ClN4O |
Purity | ≥98% |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
Fentrazamide Metabolite is an active metabolite derived from the prodrug fentrazamide, a promising candidate in the realm of antineoplastic therapy. Its mechanism of action centers on the selective disruption of crucial tumor-associated signaling cascades, thereby impeding the proliferation and advancement of malignancies.
- Specification
- Properties
- Reference Reading
- Price Product List
Synonyms | 1-(2-Chlorophenyl)-1,4-dihydrotetrazol-5-one; 1-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one; 1-(2-chlorophenyl)-2H-tetrazol-5-one |
Storage | Store at 2-8°C |
IUPAC Name | 4-(2-chlorophenyl)-1H-tetrazol-5-one |
Canonical SMILES | C1=CC=C(C(=C1)N2C(=O)NN=N2)Cl |
InChI | InChI=1S/C7H5ClN4O/c8-5-3-1-2-4-6(5)12-7(13)9-10-11-12/h1-4H,(H,9,11,13) |
InChI Key | NTLCSWYRVIMNEI-UHFFFAOYSA-N |
Boiling Point | 264.7°C at 760 mmHg |
Density | 1.64 g/cm3 |
Solubility | Soluble in Acetonitrile |
BBF-05877 | Coenzyme Q10 | Inquiry |
BBF-05781 | Emodepside | Inquiry |
BBF-02576 | Pneumocandin B0 | Inquiry |
BBF-01829 | Deoxynojirimycin | Inquiry |
BBF-04624 | Sulbactam Sodium | Inquiry |
BBF-03862 | Cefozopran hydrochloride | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
